Health
NCDC Clears Air On ‘New COVID-19 Variants Detected In Nigeria’

The Nigeria Centre for Disease Control and Prevention, NCDC, has said that the COVID-19 Omicron sub-lineages partly responsible for the current increase in COVID-19 cases in China, the United States, and the United Kingdom have not yet been detected in the country.
The NCDC disclosed this on Wednesday in an update on COVID-19 genomic surveillance signed by its Director General, Dr Ifedayo Adetifa.
The update which was made available to our correspondent showed that the Omicron sub-lineage responsible for the rise in cases in the US and UK is XBB.1.5 while BF.7 is responsible for the increased cases in China.
Adetifa, however, said B.5.2.1 has been seen in Nigeria since July 2022.
According to him, country-targeted travel restrictions including requests for PCR-negative tests from incoming travellers had little or no effect on preventing global and national circulation of omicron since the emergence of the variant and its relatives with their shorter incubation period.
He said, “The NCDC-led COVID-19 Emergency Operations Centre is monitoring COVID-19 trends in China, the United States of America, the United Kingdom, South Africa, India, and other countries with a high volume of traffic to and from Nigeria. This includes the resurgence of COVID-19 in China following the relaxation of the country’s zero-COVID policy, as well as significantly increased COVID-19 cases, admissions, and deaths in the UK and the USA over the past weeks driven in part by the usual winter exacerbations of respiratory illnesses.
“Before the recent case increase in China, the USA, the UK, and other countries, genomic surveillance has shown that the Omicron SARS-CoV-2 variant and its lineages continue to dominate in recorded infections worldwide. However, the rise in the new Omicron sub-lineages XBB.1.5 in the UK and the US, and BF.7 in China raises concern as it may spread faster than older Omicron sub-lineages (e.g., XBB or BQ) and that they are responsible in part for current increases in cases, hospitalisations, and deaths. However, the sub-lineage seen with cases in China, B.5.2.1, and BF.7 are responsible for the surge in China and do not appear to be increasing unusually in other countries.
“The NCDC continues to strengthen genomic surveillance of the COVID-19 virus in Nigeria. Since the detection of the Omicron variant in December 2021, its sub-lineage (BQ.1/BQ.1.1) has been dominant in Nigeria. None of these dominant sub-lineages in Nigeria that are also circulating elsewhere has been associated with any increases in case numbers, admissions, or deaths locally.
“The sub-lineages partly responsible for the current increase in COVID-19 cases in other countries i.e., XBB.1.5 and BF.7 have not yet been detected in the country but B.5.2.1 has been seen here since July 2022 and the others are most likely here already. BF.7 and XBB have also been circulating in South Africa since October 2022 but without any accompanying increase in cases, severe illness, or deaths.
“Regardless of COVID-19 variants in different parts of the world, severe disease, admissions, and deaths disproportionately affect the unvaccinated and those with established risk factors i.e., older people, people with co-morbidities, and the immunocompromised. The most important action for Nigerians to take is to get vaccinated against COVID-19 as the vaccine is the most important intervention for preventing severe disease, hospitalisation, and death.
“Though the COVID-19 protocols and restrictions have been eased, people at high risk for severe COVID-19 are advised to continue to adhere to the recommended non-pharmaceutical interventions such as the use of face masks, good hand and respiratory hygiene and avoidance of crowded spaces.
“COVID-19 has and continues to follow a different epidemiological course in Nigeria and most of Africa. Other Omicron sub-lineages that were associated with increases in cases, admissions and deaths elsewhere did not cause the same in Nigeria as confirmed by our genomics surveillance. This is because the population is significantly protected from a combination of natural immunity and vaccination with vaccines with a high impact on hospitalisation, and deaths. In hindsight, country-targeted travel restrictions including requests for PCR-negative tests from incoming travellers had little or no effect on preventing global and national circulation of omicron since the emergence of this variant and its relatives with their shorter incubation period.
“The NCDC will continue to pay close attention to the ongoing COVID-19 situation in other countries and gather additional surveillance data to inform actions. We are reviewing the situation again this week. At this next review and if deemed necessary, a range of actions, not limited to enhanced surveillance of travellers at airports, may be decided on and implemented.”
Health
Global Experts Tackle Stroke Management Crisis With Training In Asaba

Experts consider that stroke is a growing health crisis in Nigeria, affecting thousands of lives every year.
To tackle this challenge, the World Stroke Organization (WSO), Stroke Action Nigeria, Federal Medical Centre (FMC) Asaba, Asaba Specialist Hospital (ASH), and FMC Onitsha joined forces for an intensive four-day training program. Their mission? To equip healthcare workers with the skills to prevent, detect, and treat strokes more effectively.
The program brought together leading stroke specialists from around the world, including WSO President Prof. Jeyaraj Pandian, former WSO President Prof Sheila Martins, Dr. Rita Melifonwu, CEO of Stroke Action Nigeria and Board Member of the World Stroke Organisation, and other experts from Nigeria, India, Canada, Rwanda, and the UK. Through hands-on training and expert-led sessions, healthcare workers learned best practices for recognizing stroke symptoms, responding in emergencies, and providing life-saving care.
ALSO READ: 2027: Okpebholo Assures Tinubu With Snatch Of 17 LG Chiefs From PDP
Dr. Emmanuel Ezunu, Chief Consultant Neurologist at FMC Asaba, stressed the urgency of the training, saying, “Stroke is the leading cause of disability worldwide and the second leading cause of death. We all need to work together to reduce the burden of stroke. This training is a crucial step to ensure our health workers are well-equipped to handle every stage of stroke care.”
The training sessions took place simultaneously in multiple locations, including FMC and ASH in Asaba as well as in Onitsha, Anambra. Dr. Francis Ugoeze, Lead for the Research Study Recruitment and Implementation Team, warned about the rising risks among young people due to poor lifestyle choices. “It’s important to watch what we eat, avoid junk food, smoking, and hard drugs, and stay active,” he advised.
Dr. Melifonwu emphasized that stroke is not just a health crisis but a preventable one. “One in four adults over 25 is at risk. We need more awareness and lifestyle changes to reduce stroke cases,” she said. She also shared plans to establish ‘Life After Stroke’ centers in Nigeria, offering much-needed support for survivors, especially those struggling financially.
Dr. Chiamaka Okereke, a consultant neurologist and member of the research team, highlighted how these efforts are about more than just education—they’re about saving lives. “If more people recognize stroke symptoms early and seek medical help immediately, we can prevent many unnecessary deaths and disabilities,” she explained.
Experts at the event also called on the government to take action by increasing public awareness and investing in stroke care facilities. They emphasized the need for acute stroke units and post-stroke rehabilitation centers to provide patients with the care and support they need to recover.
This initiative represents a major step toward a future where stroke is no longer a leading cause of disability and death in Nigeria. With greater awareness, improved healthcare training, and better facilities, countless lives can be saved.
Health
Nigeria Strengthens Airport Screenings Amid Spread Of China’s HMPV Virus

The Nigerian government has increased surveillance at major international airports in response to the outbreak of Human Metapneumovirus (HMPV), recently discovered in China and now spreading to several countries, including India, Hong Kong, Malaysia, and Kazakhstan.
Port health officers have begun screening arriving passengers for symptoms of the virus, following a directive from the Minister of Health, Muhammad Ali Pate.
According to a source at Murtala Muhammad International Airport (MMIA), Lagos, “There is no cause for alarm as the Port Health Service has been mandated to start screening the passengers, and we are not taking anything to chance.”
The Human Metapneumovirus has sparked global concern after over 5,000 hospitalisations were reported in the United Kingdom due to respiratory infections linked to the virus.
READ MORE: Speed Darlington Sues IGP For N300M Over Unlawful Detention
The Nigeria Centre for Disease Control and Prevention (NCDC) has issued an advisory to monitor global developments in collaboration with the Ministry of Health and Social Welfare. Dr Jide Idris, Director-General of the NCDC, stated, “We aim to provide timely, accurate information and guidance to keep the Nigerian public informed and prepared.”
The agency also debunked rumours that the World Health Organization (WHO) had declared HMPV a Public Health Emergency of International Concern (PHEIC), urging the public to disregard such claims.
Screenings have commenced at key airports, including MMIA, Lagos, and Nnamdi Azikiwe International Airport, Abuja. Despite the heightened precautions, the Nigeria Civil Aviation Authority (NCAA) has yet to issue a formal circular to airlines on mandatory passenger checks.
The surge in respiratory infections globally has heightened pressure on health systems. In the UK alone, flu cases rose sharply over the holiday period, with over 5,000 hospitalisations reported by December 29, 2024. There has also been an increase in hospitalisations linked to COVID-19, norovirus, and RSV.
As global temperatures drop and respiratory infections continue to rise, Nigerian authorities remain vigilant, aiming to prevent the spread of HMPV within the country.
Health
Africa Leads Global Progress In HIV/AIDS Fight, Says WHO

Africa has made remarkable progress in reducing new HIV infections and AIDS-related deaths, according to the World Health Organization (WHO).
Dr. Matshidiso Moeti, WHO Regional Director for Africa, highlighted these achievements in her statement to mark this year’s World AIDS Day, themed “Take the Rights Path: My Health, My Right” on Friday.
READ ALSO: Atiku Gloats Over AUN’s Achievements Ahead Of 20th Anniversary
For the first time in 2023, the number of new HIV infections outside sub-Saharan Africa surpassed those within the region, underscoring Africa’s significant progress.
The continent is also a global leader in advancing the 95-95-95 UNAIDS targets aimed at ensuring 95% of people living with HIV know their status, 95% of those diagnosed are on treatment, and 95% of those treated achieve viral suppression.
“Seven countries have already achieved the targets, with the overall rating for the region currently at 90-82-76,” said Dr. Moeti. “About 21.3 million people are now on antiretroviral treatment, raising their life expectancy.”
Botswana and Namibia were recognized for achieving significant milestones in preventing mother-to-child HIV transmission, earning silver and bronze tier statuses, respectively, under WHO’s Path to Elimination of HIV initiative.
African countries are also adopting innovative prevention methods, including oral and long-acting injectable pre-exposure prophylaxis (PrEP) and the dipivefrine vaginal ring.
Dr. Moeti stressed that while these tools are vital, their impact depends on accessibility.
“The value of these innovations depends on their universal accessibility,” she stated, emphasizing the need for investments and policy reforms.
Dr. Moeti called for an end to stigma and discrimination, which she said continue to hinder progress.
“We have a collective obligation to protect human rights, specifically ensuring that health care is available to everyone, without any discrimination, regardless of their HIV status, background, gender, or where they live. Stigma and discrimination cannot be allowed to undermine the gains and impede our progress.”
While celebrating these advancements, Dr. Moeti noted that disease outbreaks across the region pose a challenge to already overburdened health systems.
She emphasized the importance of strong, integrated, and person-centered health care systems to meet the needs of vulnerable populations.
“Let’s take this opportunity today to acknowledge the progress, but to also renew our joint commitment to eliminating HIV.
By protecting everyone’s right to health, and reducing new HIV infections, we can achieve an AIDS-free generation and ensure the sustainability of the HIV response,” she urged.
Dr. Moeti also highlighted the crucial role of communities in shaping strategies to eliminate barriers to care.
“We must ensure their voices are heard,” she said, emphasizing that the collective efforts of governments, partners, civil society, health care providers, and communities are essential in the fight against HIV/AIDS.